Can technology-based gait training result in relevant changes of ambulatory function in people with chronic, neurological diagnoses? A longitudinal, cohort study
PLOS One · 2025
DOI: 10.1371/journal.pone.0324062 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift PLOS One, 2025. Verfasst von Eveline S Graf und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Health Sciences, ZHAW Zurich University of Applied Sciences, Winterthur, Switzerland. Hauptthemen laut MEDLINE: Gait, Exercise Therapy, Nervous System Diseases, Gait Disorders, Neurologic. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sanitas Health Insurance, SWICA Health Insurance.
Abstract (Originalsprache)
Objectives
To determine whether a six-months technology-based gait training results in relevant changes of ambulatory function in a chronic stage after a neurological event. Further, changes in quality of life will be assessed as well as the willingness to pay for technology-based gait training.
Design
Single-center, longitudinal cohort study.
Setting
One outpatient center specialized in neurological rehabilitation.
Participants
Adults with a chronic neurological diagnosis resulting in residual gait impairments.
Intervention
Six month of technology-based gait training (with Lokomat, Andago, or C-Mill) with a minimal number of trainings of 10 per month. Primary & secondary outcome measures Walking performance assessed with the 10-meter walk test, 6-minute walk test and functional ambulation category; quality of life assessed with the EQ-5D-3L and WHODAS 2.0; predicted market share and willingness to pay assessed with a choice-based conjoint analysis survey and direct question.
Results
27 participants completed three months while 20 completed six months of training. Comparing variables at baseline (BL) and after three (M3) and six (M6) months of training, both the walking speed in the 10-meter walk test (BL: 0.46m/s, M3: 0.54 m/s M6: 0.57 m/s) and the distance covered in the 6-minute walk test (BL: 149m, M3: 155m, M6: 159m) showed improvements that were below the clinically relevant change. The quality of life did not indicate a change. The direct willingness to pay was at CHF 80 which resulted in an estimated market share of 55% based on the conjoint analysis.
Conclusion
The observed, small changes in ambulatory function in patients with chronic, neurological impairments and the willingness to pay indicates the need to provide technology-based gait training in an outpatient setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- School of Health Sciences, ZHAW Zurich University of Applied Sciences, Winterthur, Switzerland.
- VAMED Rehazentrum Zürich Seefeld, Zurich, Switzerland.
- School of Management and Law, ZHAW Zurich University of Applied Sciences, Winterthur, Switzerland.
- Rehaklinik Zihlschlacht, Zihlschlacht, Switzerland.
ORCID-Profile: Eveline S Graf, Jürgen Degenfellner
Förderung
- Sanitas Health Insurance
- SWICA Health Insurance
Zitieren
APA
Graf, E. S., De Bon, D., Stahl, J., Degenfellner, J., Knechtle, D., Zutter, D., Liberatore, F., & Wirz, M. (2025). Can technology-based gait training result in relevant changes of ambulatory function in people with chronic, neurological diagnoses? A longitudinal, cohort study. PLOS One. https://doi.org/10.1371/journal.pone.0324062
Vancouver
Graf ES, De Bon D, Stahl J, Degenfellner J, Knechtle D, Zutter D, et al. Can technology-based gait training result in relevant changes of ambulatory function in people with chronic, neurological diagnoses? A longitudinal, cohort study. PLOS One. 2025. doi:10.1371/journal.pone.0324062
BibTeX
@article{Graf2025,
author = {Graf, Eveline S and De Bon, Dino and Stahl, Johanna and Degenfellner, Jürgen and Knechtle, Deborah and Zutter, Daniel and Liberatore, Florian and Wirz, Markus},
title = {Can technology-based gait training result in relevant changes of ambulatory function in people with chronic, neurological diagnoses? A longitudinal, cohort study},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0324062}
}
EUVIMED